---
title: "中國藥品監管機構將恆瑞醫藥的 SHR-1918 注射液納入優先審評程序"
description: "中國藥品監管局將恆瑞醫藥的 SHR-1918 注射劑列入優先審評"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/276838200.md"
published_at: "2026-02-25T05:42:03.000Z"
---

# 中國藥品監管機構將恆瑞醫藥的 SHR-1918 注射液納入優先審評程序

> 中國藥品監管局將恆瑞醫藥的 SHR-1918 注射劑列入優先審評

### Related Stocks

- [600276.CN - 恆瑞醫藥](https://longbridge.com/zh-HK/quote/600276.CN.md)
- [513060.CN - 博時恆生醫療保健(QDII-ETF)](https://longbridge.com/zh-HK/quote/513060.CN.md)
- [520690.CN - 博時恆生港股通創新藥精選ETF](https://longbridge.com/zh-HK/quote/520690.CN.md)
- [01276.HK - 恆瑞醫藥](https://longbridge.com/zh-HK/quote/01276.HK.md)
- [516820.CN - 平安中證醫療創新ETF](https://longbridge.com/zh-HK/quote/516820.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Hengrui Pharma Gets Nod for Solid Tumor Injection's Clinical Trials | Hengrui Pharma Gets Nod for Solid Tumor Injection's Clinical Trials | [Link](https://longbridge.com/zh-HK/news/273791098.md) |
| Palumbo Wealth Management LLC Buys New Stake in ProShares Ultra Nasdaq Biotechnology $BIB | Palumbo Wealth Management LLC acquired a new stake in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) during the third | [Link](https://longbridge.com/zh-HK/news/276735169.md) |
| Understanding the Limits of Cosmetic Injectables and When to Opt for a Facelift with Dr. Nicole Schrader | Dr. Nicole Schrader discusses the limitations of cosmetic injectables for facial rejuvenation and when to consider a fac | [Link](https://longbridge.com/zh-HK/news/276776925.md) |
| China Medical System Gets China Acceptance for Atopic Dermatitis Drug | China Medical System Gets China Acceptance for Atopic Dermatitis Drug | [Link](https://longbridge.com/zh-HK/news/276718382.md) |
| Shanghai Fosun Pharmaceutical Units Trial Nod for Lung Cancer Drug in China | Shanghai Fosun Pharmaceutical Units Trial Nod for Lung Cancer Drug in China | [Link](https://longbridge.com/zh-HK/news/276886600.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。